A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Jarden: reassuring to see a more 'bullish' horticulture outlook
Finance

Jarden: reassuring to see a more 'bullish' horticulture outlook

Scales has had a tough year but there are signs of new growth. 

Fonterra fattens margins when its farmers are getting squeezed
Finance

Fonterra fattens margins when its farmers are getting squeezed

The co-op released its quarter one results on Thursday.

Riley Kennedy 08 Dec 2023
Fonterra lifts payout, earning forecast
Finance

Fonterra lifts payout, earning forecast

The lift comes after the recent lift in global prices.

Riley Kennedy 07 Dec 2023